Trial intelligence / Profile preview

Propacetamol in AF Ablation

NCT02515188Completed

Sponsor
Yonsei University
Start
Aug 2015
Primary completion
Jun 2016
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in Atrial fibrillation (AFib) comparing Propacetamol Group with Placebo Group (2 arms). Primary endpoint: Total Amount of Opioid Consumption at 1 day. Started Aug 2015; status: completed.

02

Drugs

propacetamol
03

Conditions

Atrial fibrillation (AFib)

Beyond the preview

Go deeper on NCT02515188.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02515188.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call